Gender difference and drug challenge in Brugada syndrome.
Shimizu
Wataru
W
D000404:Ajmaline; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D002037:Bundle-Branch Block / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*; D015897:Comorbidity; D003645:Death, Sudden / Q000453:epidemiology; D004562:Electrocardiography / Q000379:methods*; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D020125:Mutation, Missense; D062554:NAV1.5 Voltage-Gated Sodium Channel; D010375:Pedigree; D010641:Phenotype; D017678:Sex Distribution; D015222:Sodium Channels / Q000235:genetics*; D013030:Spain / Q000453:epidemiology; D013577:Syndrome
D000889:Anti-Arrhythmia Agents; D062554:NAV1.5 Voltage-Gated Sodium Channel; D015222:Sodium Channels; D000404:Ajmaline